Cargando…
The Landscape of Novel Therapeutics and Challenges in Glioblastoma Multiforme: Contemporary State and Future Directions
Background: Glioblastoma multiforme is a malignant intracranial neoplasm that constitutes a therapeutic challenge because of the associated high morbidity and mortality given the lack of effective approved medication and aggressive nature of the tumor. However, there has been extensive research rece...
Autores principales: | Khaddour, Karam, Johanns, Tanner M., Ansstas, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696377/ https://www.ncbi.nlm.nih.gov/pubmed/33202642 http://dx.doi.org/10.3390/ph13110389 |
Ejemplares similares
-
BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma
por: Khaddour, Karam, et al.
Publicado: (2021) -
Signaling pathways and therapeutic approaches in glioblastoma multiforme (Review)
por: Khabibov, Marsel, et al.
Publicado: (2022) -
Glioblastoma multiforme: State of the art and future therapeutics
por: Wilson, Taylor A., et al.
Publicado: (2014) -
Clinical outcomes and longitudinal circulating tumor DNA changes after treatment with nivolumab and olaparib in immunotherapy relapsed melanoma with detected homologous recombination deficiency
por: Khaddour, Karam, et al.
Publicado: (2021) -
Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
por: Khaddour, Karam, et al.
Publicado: (2020)